PFM Health Sciences’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-150,200
| Closed | -$11M | – | 58 |
|
|
2025
Q1 | $11M | Buy |
+150,200
| New | +$11M | 0.8% | 31 |
|
|
2023
Q1 | – | Sell |
-576,800
| Closed | -$39.1M | – | 76 |
|
|
2022
Q4 | $39.1M | Hold |
576,800
| – | – | 1.4% | 27 |
|
|
2022
Q3 | $31.6M | Hold |
576,800
| – | – | 1.14% | 38 |
|
|
2022
Q2 | $38.1M | Buy |
576,800
+124,500
| +28% | +$8.23M | 1.45% | 28 |
|
|
2022
Q1 | $30M | Sell |
452,300
-333,448
| -42% | -$22.1M | 1.12% | 38 |
|
|
2021
Q4 | $45.8M | Hold |
785,748
| – | – | 1.56% | 29 |
|
|
2021
Q3 | $47.2M | Buy |
785,748
+577,148
| +277% | +$34.7M | 1.39% | 27 |
|
|
2021
Q2 | $12.5M | Sell |
208,600
-601,800
| -74% | -$36M | 0.39% | 55 |
|
|
2021
Q1 | $40.3M | Sell |
810,400
-284,200
| -26% | -$14.1M | 1.23% | 25 |
|
|
2020
Q4 | $54.7M | Buy |
1,094,600
+706,700
| +182% | +$35.3M | 1.92% | 13 |
|
|
2020
Q3 | $21.3M | Sell |
387,900
-247,700
| -39% | -$13.6M | 0.98% | 33 |
|
|
2020
Q2 | $33.6M | Buy |
+635,600
| New | +$33.6M | 1.74% | 16 |
|